GenomeQuest Appoints Richard Resnick as Acting CEO
September 16, 2010
Westborough, MA - GenomeQuest, Inc. today announced the appointment of Richard Resnick as Acting CEO of the company. He succeeds former CEO Ron Ranauro, who has resigned. During this transition, Resnick will retain his role as vice president of products and services at GenomeQuest. “I want to thank Ron for his strong contributions over the [...]
Pall Corporation’s New GeneDisc® Rapid Microbiology System Advances Quality Assurance Analysis
September 16, 2010
Dramatic Time Savings for Biopharma Manufacturing Using Novel qPCR Technology PORT WASHINGTON, N.Y. - Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, today announced the introduction of the GeneDisc® Rapid Microbiology System for advanced microbial quality monitoring. This system represents Pall’s latest quality assurance innovation for the pharmaceutical manufacturing industry. “The [...]
Research Team from Fred Hutchinson Cancer Center Wins 2010 BioFlux Innovation Award
September 16, 2010
Group will use BioFlux System for advanced screening applications applicable to women’s reproductive health South San Francisco, California, September 16, 2010 – Fluxion Biosciences, Inc. announced today that a research team from Fred Hutchinson Cancer Center has won the 2010 BioFlux Innovation Award competition. Laura Sycuro, Ph.D., a post-doctoral research fellow in the lab of [...]
Bioo Scientific Launched Color Endpoint Assays for In Vivo AST and LDH Analysis
September 16, 2010
Today Bioo Scientific launched the MaxDiscovery™ Aspartate Transaminase (AST) and Lactate Dehydrogenase (LDH) Color Endpoint Assays for in vivo toxicity analysis. Austin, TX - Bioo Scientific announced the availability of the MaxDiscovery™ Aspartate Transaminase (AST) and Lactate Dehydrogenase (LDH) Color Endpoint Assays which use a proprietary, innovative technology for visible detection of in vivo toxicity [...]
September 15, 2010
Washington, D.C. and London, UK – Diaceutics Limited (www.diaceutics.com) and London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, today announce a strategic partnership to develop software decision tools that will provide biopharmaceutical companies with rapid and extensive access to the world’s leading academic biomarker research groups. The [...]
September 15, 2010
East Norwalk, CT - Seven weeks of on-site tests were recently completed at a major pipeline company in the Southwest to determine the effectiveness of the Wilks InfraSpec VFA-IR Spectrometer, Model EB, for detecting biodiesel contamination in diesel fuels about to enter the pipeline. Over 20 different diesel fuels were tested for the presence of [...]
September 15, 2010
Uncovering Mutations Found in Deadly Transmissible Cancer Could Help Conservation Efforts SAN DIEGO - Researchers from Illumina, Inc. (NASDAQ:ILMN) and the Wellcome Trust Sanger Institute have used Illumina's next generation sequencing technology to create a draft genome sequence for the endangered Tasmanian devil, and will use this to find genetic mutations in the transmissible cancer [...]
New England Biolabs Receives Award to Develop Novel Enzymatic Reagents for Epigenetic Studies
September 15, 2010
Ipswich, MA - New England Biolabs (NEB) has announced that it has received fast track SBIR funding of $1.22 million to fund the research and development of novel enzymatic reagents for epigenetic studies. New England Biolabs is committed to developing tools that advance epigenetics research and discovery, and offers a growing range of products for [...]
Completion of Merger with the Wholly Owned Subsidiary Genpoint AS
September 15, 2010
Reference is made to the stock exchange notification dated 28 May 2010 regarding the merger between NorDiag ASA ("NorDiag") and its wholly owned subsidiaryGenpoint AS. The merger was motivated by cost synergies. The completion of the merger has now been registered with the Norwegian Register of Business Enterprises. The merger is carried out with accounting [...]
BioCision Appoints Chief Operating Officer, Expands Corporate Advisory Board
September 15, 2010
Appointments Come as Company Experiences Rapid Growth in New Markets and Regions MILL VALLEY, Calif. - BioCision LLC, the CoolPrep™ company, announced today the expansion of its management team, with the appointment of industry veteran Hugh Douglas to the position of chief operating officer. The company also announced that it has added a group of [...]
